Source link : https://www.newshealth.biz/health-news/t-dxd-effective-in-some-with-her2-breast-cancer/
A study demonstrated the efficacy of trastuzumab deruxtecan (Enhertu) in patients with HER2-positive advanced or metastatic breast cancer, including those with brain metastases. Senior author Nancy Lin, MD, presented these primary results of the DESTINY-Breast12 trial at the European Society for Medical Oncology Congress 2024. These findings were published simultaneously in the journal Nature Medicine. […]
Author : News Health
Publish date : 2024-09-15 18:09:05
Copyright for syndicated content belongs to the linked Source.
inHealth